Lupin Limited
NSE: LUPIN · Healthcare
₹2,175.50
-12.50 (-0.57%)
Last close · 30 Aug 2026, 11:55 am IST
- Open
- ₹2,182.60
- Day high
- ₹2,189.90
- Day low
- ₹2,158.10
- Volume
- 5.45 L
- Prev close
- ₹2,188.00
HealthcareDrug Manufacturers - Specialty & GenericPart of:All NSE StocksNifty 200Nifty 500Nifty HealthcareNifty Midcap 100Nifty Midcap 150Nifty Midcap 50Nifty Midcap SelectNifty MidSmallcap 400Nifty Pharma
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 1,08,388 Cr
- Price
- 2,370.50
- P/E (TTM)
- 20.37
- P/E (Fwd)
- 23.17
- P/B
- 4.83
- EV/EBITDA
- 13.47
- EV/Revenue
- 3.83
- PEG
- —
- Div Yield
- 0.76%
- 52W High
- 2,529.50
- 52W Low
- 1,836.80
- Beta
- 0.18
Profitability & income
- Revenue (TTM)
- 27,958 Cr
- Net Income (TTM)
- 5,333 Cr
- EBITDA
- 7,953 Cr
- Gross Margin
- 71.51%
- Op. Margin
- 24.22%
- Net Margin
- 19.07%
- ROE
- 26.91%
- ROA
- 12.71%
- EPS (TTM)
- 116.39
- EPS (Fwd)
- 102.30
Financial health
- Total Debt
- 6,616 Cr
- Total Cash
- 7,895 Cr
- Debt/Equity
- 29.39
- Current Ratio
- 1.90
- Quick Ratio
- 1.26
- Book Value
- 491.02
- Free Cash Flow
- 3,722 Cr
- Op. Cash Flow
- 7,334 Cr
Growth
- Revenue Growth
- 31.90%
- Earnings Growth
- 89.00%
- Earnings QoQ
- 89.00%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 7,392 Cr | 1,460 Cr | 2,495 Cr | 1,724 Cr | 5,540 Cr | — | 6,616 Cr | 22,448 Cr |
| 2025-12-31 | 7,100 Cr | 1,176 Cr | 1,950 Cr | 1,897 Cr | 5,222 Cr | — | — | — |
| 2025-06-30 | 6,164 Cr | 1,219 Cr | 1,693 Cr | 3,228 Cr | 4,392 Cr | — | — | — |
| 2025-03-31 | 5,562 Cr | 773 Cr | 1,378 Cr | 899 Cr | 3,876 Cr | — | 5,448 Cr | 17,204 Cr |
| 2024-12-31 | 5,619 Cr | 855 Cr | 1,410 Cr | 1,094 Cr | 3,897 Cr | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 27,488 Cr | 5,333 Cr | 8,661 Cr | 6,818 Cr | 19,377 Cr | 7,335 Cr | 6,616 Cr | 22,448 Cr |
| 2025-03-31 | 22,192 Cr | 3,282 Cr | 5,455 Cr | 4,345 Cr | 14,736 Cr | 3,000 Cr | 5,448 Cr | 17,204 Cr |
| 2024-03-31 | 19,656 Cr | 1,914 Cr | 3,898 Cr | 2,797 Cr | 12,510 Cr | 3,648 Cr | 2,922 Cr | 14,290 Cr |
| 2023-03-31 | 16,270 Cr | 430 Cr | 1,837 Cr | 889 Cr | 9,005 Cr | 1,897 Cr | 4,542 Cr | 12,465 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for LUPIN?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in